mike_mod said:Denials are usually procedural rather than clinical, and the order that works reflects that.
My insurance denied my PA related to cost and coverage. Has anyone successfully appealed? I'm considering going compounded instead.
A narrower follow-up, since the general answer is now clear:
What would you measure differently if you were starting again?
raj_cambridge said:My insurance denied my PA related to cost and coverage.
Financial impact of cost and coverage weight loss beyond medication cost:
- Groceries: SAVED $220/month (eating less)
- Restaurants: SAVED $150/month (fewer meals out)
- Alcohol: SAVED $100/month (stopped drinking)
- Life insurance: Premium REDUCED by $30/month (lower BMI)
- Copays: SAVED $50/month (fewer BP/cholesterol meds)
Net impact after medication cost: approximately BREAKING EVEN. The medication pays for itself through reduced food spending and healthcare costs. This surprised me.
PeptideDetective — Independent Peptide Analytics
Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.
View ResultsClosing the loop on my own question.
Follow-up — getting the denial reason in writing was the step that mattered. It named the criterion, and the criterion was a document I already had.
Dr.NephBHM_UK said:Financial impact of cost and coverage weight loss beyond medication cost: Groceries: SAVED $220/month (eating less) Restaurants: SAVED $150/month…
Insurance coverage hack for cost and coverage: if your insurance denies brand Wegovy/Ozempic, consider these alternatives:
- Prior authorization appeal with peer-to-peer review
- Manufacturer copay card (for commercial insurance)
- Patient assistance programs (Novo Nordisk, Eli Lilly)
- Compounded medication from a 503B pharmacy ($134/month)
- Canadian pharmacy (requires prescription, ~40-60% savings)
Don't let cost prevent access to effective treatment. There are options at every price point.